| |
| |
|
| Insider
Information: |
Coles N Anthony |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
1,005,229 |
|
|
Indirect Shares
|
124,745 |
|
|
| Direct
Value |
$39,019,319 |
|
|
|
Indirect Value
|
$5,215,846 |
|
|
| Total
Shares |
1,129,974 |
|
|
| Total
Value |
$44,235,164 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -2.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
SVP, Comm. Ops. |
2005-02-03 |
74,540 |
2005-02-03 |
2,076 |
Premium* |
|
|
NPS Pharmaceuticals Inc |
NPSP |
President, COO & Direc... |
2008-03-17 |
220,066 |
2007-01-31 |
0 |
Premium* |
|
|
Onyx Pharmaceuticals Inc |
ONXX |
Chairman & CEO, Director |
2013-10-01 |
0 |
2008-03-31 |
0 |
Premium* |
|
|
Laboratory Corp of America |
LH |
Director |
2013-02-15 |
2,584 |
2011-01-03 |
0 |
Premium* |
|
|
Crispr Therapeutics Ag |
CRSP |
Director |
2016-10-24 |
0 |
2016-10-24 |
70,000 |
Premium* |
|
|
McKesson Corp |
MCK |
Director |
2020-08-17 |
0 |
2018-07-25 |
0 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-02 |
1,393 |
2019-01-02 |
0 |
Premium* |
|
|
Kineta Ord Shs |
KA |
Executive Chair, Direc... |
2021-02-01 |
691,008 |
2021-02-01 |
52,669 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
|
2024-06-03 |
15,638 |
2022-12-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
117 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONXX |
Onyx Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-04-03 |
4 |
OE |
$28.55 |
$499,899 |
D/D |
17,278 |
131,198 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
|
– • – |
2023-11-14 |
4 |
AS |
$25.13 |
$573,455 |
D/D |
(22,824) |
2,704 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-17 |
4 |
AS |
$650.00 |
$585,000 |
D/D |
(900) |
902 |
0 |
% |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-06-05 |
4 |
AS |
$90.00 |
$590,580 |
D/D |
(6,562) |
131,198 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2012-08-01 |
4 |
AS |
$74.37 |
$655,943 |
D/D |
(8,820) |
154,033 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
|
– • – |
2023-11-07 |
4 |
AS |
$25.02 |
$677,555 |
D/D |
(27,076) |
2,704 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-13 |
4 |
OE |
$345.47 |
$690,940 |
D/D |
2,000 |
2,902 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-04-03 |
4 |
AS |
$89.30 |
$868,620 |
D/D |
(9,705) |
113,920 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2012-07-25 |
4 |
AS |
$73.97 |
$879,007 |
D/D |
(11,883) |
162,853 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
|
– • – |
2023-11-02 |
4 |
AS |
$25.19 |
$972,239 |
D/D |
(38,599) |
2,704 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Director |
– • – |
2016-10-24 |
4 |
A |
$14.00 |
$980,000 |
I/I |
70,000 |
70,000 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-03-28 |
4 |
AS |
$90.00 |
$984,420 |
D/D |
(10,938) |
108,454 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Chairman & CEO |
• • – |
2013-04-01 |
4 |
AS |
$86.14 |
$1,001,722 |
D/D |
(11,629) |
123,625 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
|
– • – |
2023-09-07 |
4 |
AS |
$24.07 |
$1,203,415 |
D/D |
(50,000) |
2,704 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-13 |
4 |
AS |
$625.00 |
$1,250,000 |
D/D |
(2,000) |
902 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
CEO and Chairperson |
• • – |
2023-04-11 |
4 |
AS |
$25.06 |
$1,253,130 |
D/D |
(50,000) |
2,704 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
CEO and Chairperson |
• • – |
2023-03-02 |
4 |
AS |
$27.11 |
$1,274,377 |
D/D |
(47,000) |
2,704 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
CEO and Chairperson |
• • – |
2022-12-09 |
4 |
AS |
$26.62 |
$1,333,300 |
D/D |
(50,000) |
2,704 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
|
– • – |
2023-07-11 |
4 |
AS |
$30.03 |
$1,501,340 |
D/D |
(50,000) |
2,704 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
|
– • – |
2023-11-03 |
4 |
AS |
$25.43 |
$1,561,458 |
D/D |
(61,401) |
2,704 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
CEO and Chairperson |
• • – |
2023-05-04 |
4 |
AS |
$31.36 |
$1,573,434 |
D/D |
(50,000) |
2,704 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
CEO and Chairperson |
• • – |
2023-06-01 |
4 |
AS |
$32.60 |
$1,630,070 |
D/D |
(50,000) |
2,704 |
0 |
% |
|
| CERE |
Cerevel Therapeutics Hold... |
CEO and Chairperson |
• • – |
2023-02-07 |
4 |
AS |
$33.04 |
$1,656,401 |
D/D |
(50,000) |
2,704 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
Director |
– • – |
2021-08-18 |
4 |
OE |
$345.47 |
$1,761,897 |
D/D |
5,100 |
6,002 |
0 |
- |
|
| CERE |
Cerevel Therapeutics Hold... |
|
– • – |
2024-06-03 |
4 |
AS |
$40.61 |
$2,030,520 |
D/D |
(50,000) |
15,638 |
0 |
- |
|
117 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
